Triglyceride landmark trials

Jump to navigation Jump to search

Triglyceride Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

Triglyceride Laboratory Test

High Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications
History and Symptoms
Physical Examination

Low Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Treatment

Lifestyle modification

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

Triglyceride landmark trials On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Triglyceride landmark trials

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Triglyceride landmark trials

CDC on Triglyceride landmark trials

Triglyceride landmark trials in the news

Blogs on Triglyceride landmark trials

Directions to Hospitals Treating Triglyceride

Risk calculators and risk factors for Triglyceride landmark trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Landmark Trials

Niacin

AIM HIGH Study

Omega-3 Fatty Acids

References

Template:WH Template:WS